The interactions of docetaxel with tumor microenvironment.

International immunopharmacology 2023 Jun

filter terms:

There are several interactions within the tumor microenvironment (TME) that affect the response of cancer cells to therapy. There are also a large number of cells and secretions in TME that increase resistance to therapy. Following the release of immunosuppressive, pro-angiogenic, and metastatic molecules by certain cells such as tumor-associated macrophages (TAMs), cancer-associated fibroblasts (CAFs), and cancer cells, immune evasion, angiogenesis, and metastasis may be induced. However, natural killer (NK) cells and cytotoxic CD8 + T lymphocytes (CTLs) can responsively release anticancer molecules. In addition, anticancer drugs can modulate these cells and their interactions in favor of either cancer resistance or therapy. Docetaxel belongs to taxanes, a class of anti-tumor drugs, which acts through the polymerization of tubulin and the induction of cell cycle arrest. Also, it has been revealed that taxanes including docetaxel affect cancer cells and the other cells within TME through some other mechanisms such as modulation of immune system responses, angiogenesis, and metastasis. In this paper, we explain the basic mechanisms of docetaxel interactions with malignant cells. Besides, we review the diverse effects of docetaxel on TME and cancer cells in consequence. Lastly, the modulatory effects of docetaxel alone or in conjunction with other anticancer agents on anti-tumor immunity, cancer cell resistance, angiogenesis, and metastasis will be discussed. Copyright © 2023 Elsevier B.V. All rights reserved.

Citation

Reena Gupta, Mustafa M Kadhim, Abduladheem Turki Jalil, Mohammed Qasim Alasheqi, Fahad Alsaikhan, Nurkhan Khalimovna Mukhamedova, Andrés Alexis Ramírez-Coronel, Zanko Hassan Jawhar, Pushpamala Ramaiah, Masoud Najafi. The interactions of docetaxel with tumor microenvironment. International immunopharmacology. 2023 Jun;119:110214